Sexual Dysfunction

Study Shows No Difference between Drug Therapy and Placebo

Published in Women's Health Weekly, April 8th, 2000

Women who take fluoxetine drug therapy sometimes self-report a decrease in sexual function, according to scientists. A randomized, controlled study performed by researchers at Lilly Corporation shows that two drugs, amantadine and buspirone, are no better than placebo in treating this type of dysfunction in females.

The study was reported in the American Journal of Psychiatry (D. Michelson et al., "Female dysfunction associated with antidepressant administration: A randomized, placebo controlled study of pharmacologic intervention," Am J of Psychiatry, 2000;157(2):239-243).

Women who had been on fluoxetine therapy for at least eight...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-04-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry